In vitro permeation and irritation of benzoyl peroxide-containing products

International Journal of Pharmaceutics

Volumn 133, Issue 1-2, 1996, Pages 215-222

  Fares, Hani M ^a   Chatterjee, Suzanne ^a   Hayward, Marshall ^a  

^a SmithKline Beecham Consumer Healthcare   (United States)

Author keywords

Benzoyl peroxide; Irritation; MTT; Permeation; Silastic; Sodium fluorescein

Indexed keywords

BENZOYL PEROXIDE;

ARTICLE; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIFFUSION; DIFFUSION COEFFICIENT; DRUG FORMULATION; DRUG RELEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; KERATINOCYTE; MEASUREMENT; MODEL; PRIORITY JOURNAL; SKIN IRRITATION;

EID: 0029982560     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/0378-5173(96)04444-4     Document Type: Article

References (14)

1. Billow, J.A., Acne Products. In Handbook of Nonprescription Drugs. 10th Ed., American Pharmaceutical Association, Washington, DC, 1993, pp. 516-517.
2. Chellquist, E.M. and Gorman, W.G., Benzoyl peroxide solubility and stability in hydric solvents. Pharm. Res., 9 (1992) 1341-1346.
3. Dick, I.P. and Scott, R.C., Pig ear skin as an in-vitro model for human skin permeability. J. Pharm. Pharmacol., 44 (1992) 640-645.
4. Fulton, J.E. and Bradley, S., Studies on the mechanism of action of topical benzoyl peroxide in acne vulgaris. J. Cutan. Pathol., 1 (1974) 191-194.
5. Higuchi, T., Rate of release of medicaments from ointment bases containing drugs in suspension. J. Pharm. Sci., 50 (1961) 874-875.
6. Houk, J. and Guy, R., Membrane models for skin penetration studies. Chem. Rev., 88 (1988) 455-471.
7. MatTek Corporation Ltd. Literature supplied by the manufacturer of the tissue. MatTek Corporation, Ashland, MA.
8. Mena, P., Martinez, R. and Gallardo, V., A topical formulation for benzoyl peroxide. Factors affecting release of benzoyl peroxide in topical formulations. Cosmet. Toiletr., 109 (1994) 75-80.
9. Morimoto, Y., Hatanaka, T., Sugibayashi, K. and Omiya, H., Prediction of skin permeability of drugs: Comparison of human and hairless rat skin. J. Pharm. Pharmacol., 44 (1992) 634-639.
10. Nacht, S., Yeung, D., Beasley, J., Anjo, M. and Maibach, H., Benzoyl peroxide: Percutaneous penetration and metabolic disposition. J. Am Acad. Dermatol., 4 (1981) 31-37.
11. Slivka, S.R., Landeen, L.K., Zrigler, F., Zimber, M.P. and Bartel, R.L., Characterization, barrier function, and drug metabolism of an in vitro skin model. J. Investig. Dermatol., 100 (1993) 40-46.
12. Wester, R.C., Patel, R., Nacht, S., Leyden, J., Melendres, J. and Maibach, H., Controlled release of benzoyl peroxide from a porous microsphere polymeric system can reduce topical irritancy. J. Am. Acad. Dermatol., 24 (1991) 720-726.
13. Yang, J.J. and Krueger, A., Evaluation of two commercial human skin cultures for in vitro percutaneous absorption. In Vitro Toxicol., 5 (1992) 211-217.
14. Yeung, D., Nacht, S., Bucks, D. and Maibach, H., Benzoyl peroxide: Percutaneous penetration and metabolic disposition. II. Effect of concentration. J. Am. Acad. Dermatol., 9 (1983) 920-924.